Peroxisome proliferator activated receptor (PPAR)-gamma concentrations in childhood obesity

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 73, Issue 4, 2013, Pages 355-360

  Akyürek, Nesibe ^a   Aycan, Zehra ^a   Çetinkaya, Semra ^a   Akyürek, Ömer ^b   Yilmaz Aǧladioǧlu, Sebahat ^a   Ertan, Ülker ^a  

^a Dr Sami Ulus Gynaecology   (Turkey)

^b MEVLANA UNIVERSITY   (Turkey)

Author keywords

Children; Insulin resistance; Obesity; PPAR ; Waist circumference

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL; LIPID;

ADOLESCENT; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; VENOUS BLOOD; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; CASE CONTROL STUDY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ADOLESCENT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; PEDIATRIC OBESITY; PPAR GAMMA; WAIST CIRCUMFERENCE;

EID: 84879071187     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.786121     Document Type: Article

References (25)

1. ILSI European Overweight and Obesity in Children Task Force. Overweight and obesity in European children and adolescents: Causes and consequences-prevention and treatment. The International Live Science Institute. Europe Report Series 2000 : 4-22
2. Alemzadeh R, L ifshitz F. C hildhood obesity. In:Lifshitz F, editor. Pediatric endocrinology, 4th ed. New York: Marcel Dekker; 2003. pp 823-58
3. Caprio S, T amborlane WV. M etabolic impact of obesity in childhood. Endocrinol Metab Clin North Am 1999; 28 : 731-47
4. Omi T, B renig B, S pilar K S, I wamoto S, S tranzinger G, Neuenschwander S. Identifi cation and characterization of novel peroxisome proliferator-activated receptorgamma (PPAR-gamma) transcriptional variants in pig and human. J Anim Breed Genet 2005; 122(Suppl. 1) : 45-53
5. Dubois M, P attou F, K err-Conte J, G myr V, V andewalle B, Desreumaux P, Auwerx J, Schoonjans K, Lefebvre J. Expression of peroxisome proliferatoractivated receptor gamma (PPARgamma) in normal human pancreatic islet cells. Diabetologia 2000; 43 : 1165-9.
6. Yamauchi T, K amon J, W aki H, M urakami K, M otojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) defi-ciency and PPARgamma agonist improve insulin resistance. J Biol Chem 2001; 276 : 41245-54
7. Cheng L, D ing G, Q in Q, H uang Y, L ewis W, H e N, E vans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 2004; 10 : 1245-50
8. Bundak R, F urman A, G unoz H, D arendeliler F, B as F, Neyzi O. Body mass index references for Turkish children. Acta Paediatr 2006; 95 : 194-8.
9. Hatipoglu N, O zturk A, M azicioglu MM, K urtoglu S, Seyhan S, Lokoglu F. Waist circumference percentiles for 7-to 17-year-old Turkish children and adolescents. Eur J Pediatr 2008; 167 : 383-9.
10. Tümer N, Yal çinkaya F, I nce E, E kim M, K ös e K, C akar N, Kara N, Ozkaya N, Ensari C, Onder S. Blood pressure nomograms for children and adolescents in Turkey. Pediatr Nephrol 1999; 13 : 438-43
11. Zimmet P, A lberti G, K aufman F, T ajima N, S ilink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S. International Diabetes Federation Task Force on epidemiology and prevention of diabetes. The metabolicsyndrome in children and adolescents. Lancet 2007; 369 : 2059-61
12. Keskin M, K urtoglu S, K endirci M, A tabek ME, Y azici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115 : 500-3.
13. Tanner J M. G rowth at adolescence, 2nd ed. O xford, UK: Blackwell Scientifi c Publications; 1962
14. PPAR 〈 & ©. Complete Transcription Factor Assay Kit Catalog no.: 10008878 Cayman Chemical Company, Ann Arbor, USA 2006
15. Zimmet P, A lberti KG, K aufman F, T ajima N, S ilink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S. IDF Consensus Group. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes 2007; 8 : 299-306
16. Cook S, A uinger P, L i C, F ord ES. M etabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr 2008; 152 : 165-70
17. Moller DE, B erger JP. R ole of PPARs in the regulation of obesity-related insulin sensitivity and infl ammation. Int J Obes Relat Metab Disord 2003; 27(Suppl. 3) :S17-21
18. Picard F, A uwerx J. P PAR(gamma) and glucose homeostasis. Annu Rev Nutr 2002; 22 : 167-97
19. Lagou V, S cott R A, M anios Y, C hen TL, W ang G, Grammatikaki E, Kortsalioudaki C, Liarigkovinos T, Moschonis G, Roma-Giannikou E, Pitsiladis YP. Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study. Obesity (Silver Spring) 2008; 16 : 913-8.
20. Li X, L indquist S, A ngsten G, Y i J, O lsson T, H ernell O. Adiponectin and peroxisome proliferator-activated receptor gamma expression in subcutaneous and omental adipose tissue in children. Acta Paediatr 2008; 97 : 630-5.
21. Johansson LE, D anielsson P, N orgren S, M arcus C, Ridderstr åle M. Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity. Int J Pediatr Obes 2009; 4 : 119-25
22. Han G P, R en J Y, Q in L, S ong J X, W ang L, C hen H. High density lipoprotein suppresses lipoprotein associated phospholipase A2 in human monocytes-derived macrophages through peroxisome proliferator-activated receptor-© pathway. Chin Med J (Engl) 2012; 125(24) : 4474-80
23. Chinetti G, L estavel S, B ocher V, R emaley A T, N eve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B. PPAR-alpha and PPARgamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 2001; 7 : 53-8.
24. Schupp M, J anke J, C lasen R, U nger T, K intscher U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-g activity. Circulation 2004; 109 : 2054-7.
25. Pershadsingh HA, K urtz T W. I nsulin-sensitizing effects of telmisartan: Implications for treating insulin-resistant hypertension and cardiovascular disease. Diabetes Care 2004; 27 : 1015